Dual energy scanned projection radiography

  • 文章类型: Journal Article
    目的:比较常规非对比CT的诊断性能,双能谱CT,和化学位移MRI(CS-MRI)可区分低脂腺瘤(非造影CT>10-HU)与非腺瘤。
    方法:回顾性分析了110例患者(男69例,女41例,平均年龄66.5±13.4岁),其中80例贫脂腺瘤和30例非腺瘤患者接受了非对比双层能谱CT和CS-MRI检查。对于每个病变,常规120kVp图像上的非对比衰减,ΔHU指数([虚拟单能140-keV和40-keV图像之间的衰减差]/常规衰减×100),并对信号强度指数(SI指数)进行定量。使用Mann-WhitneyU检验在腺瘤和非腺瘤之间比较每个参数。确定受试者工作特征曲线下面积(AUC)和实现腺瘤诊断的>95%特异性的敏感性。
    结果:腺瘤的常规非对比剂衰减低于非腺瘤(22.4±8.6HUvs32.8±48.5HU),而腺瘤中的ΔHU指数(148.0±103.2vs19.4±25.8)和SI指数(41.6±19.6vs4.2±10.2)较高(所有,p<0.001)。ΔHU指数表现优于常规非对比衰减(AUC:0.919[95%CI:0.852-0.963]vs0.791[95%CI:0.703-0.863];灵敏度:75.0%[60/80]vs27.5%[22/80],两者p<0.001),接近SI指数(AUC:0.952[95%CI:0.894-0.984],灵敏度85.0%[68/80],两者p>0.05)。ΔHU指数和SI指数对减弱腺瘤(≤25HU)的敏感性均为96.0%(48/50)。对于超衰减(>25HU)腺瘤,SI指数显示出比ΔHU指数更高的灵敏度(66.7%[20/30]对40.0%[12/30],p=0.022)。
    结论:非对比能谱CT和CS-MRI在区分低脂腺瘤和非腺瘤方面优于常规非对比CT。虽然CS-MRI对测量>25HU的腺瘤表现出优异的敏感性,非对比能谱CT为测量≤25HU的腺瘤提供了很高的鉴别值。
    结论:谱衰减分析提高了非造影CT对鉴别贫脂肾上腺腺瘤的诊断效能,可能作为CS-MRI的替代方案,并消除了在不确定的肾上腺偶发瘤中进行额外诊断检查的必要性,特别是对于测量≤25HU的病变。
    结论:随着腹部CT的使用越来越频繁,偶然发现的肾上腺病变增加。非对比能谱CT和CS-MRI对非腺瘤的鉴别低脂腺瘤优于常规非对比CT。对于测量≤25HU的病变,谱CT可以消除额外评估的需要。
    OBJECTIVE: To compare the diagnostic performance of conventional non-contrast CT, dual-energy spectral CT, and chemical-shift MRI (CS-MRI) in discriminating lipid-poor adenomas (> 10-HU on non-contrast CT) from non-adenomas.
    METHODS: A total of 110 patients (69 men; 41 women; mean age 66.5 ± 13.4 years) with 80 lipid-poor adenomas and 30 non-adenomas who underwent non-contrast dual-layer spectral CT and CS-MRI were retrospectively identified. For each lesion, non-contrast attenuation on conventional 120-kVp images, ΔHU-index ([attenuation difference between virtual monoenergetic 140-keV and 40-keV images]/conventional attenuation × 100), and signal intensity index (SI-index) were quantified. Each parameter was compared between adenomas and non-adenomas using the Mann-Whitney U-test. The area under the receiver operating characteristic curve (AUC) and sensitivity to achieve > 95% specificity for adenoma diagnosis were determined.
    RESULTS: Conventional non-contrast attenuation was lower in adenomas than in non-adenomas (22.4 ± 8.6 HU vs 32.8 ± 48.5 HU), whereas ΔHU-index (148.0 ± 103.2 vs 19.4 ± 25.8) and SI-index (41.6 ± 19.6 vs 4.2 ± 10.2) were higher in adenomas (all, p < 0.001). ΔHU-index showed superior performance to conventional non-contrast attenuation (AUC: 0.919 [95% CI: 0.852-0.963] vs 0.791 [95% CI: 0.703-0.863]; sensitivity: 75.0% [60/80] vs 27.5% [22/80], both p < 0.001), and near equivalent to SI-index (AUC: 0.952 [95% CI: 0.894-0.984], sensitivity 85.0% [68/80], both p > 0.05). Both the ΔHU-index and SI-index provided a sensitivity of 96.0% (48/50) for hypoattenuating adenomas (≤ 25 HU). For hyperattenuating (> 25 HU) adenomas, SI-index showed higher sensitivity than ΔHU-index (66.7% [20/30] vs 40.0% [12/30], p = 0.022).
    CONCLUSIONS: Non-contrast spectral CT and CS-MRI outperformed conventional non-contrast CT in distinguishing lipid-poor adenomas from non-adenomas. While CS-MRI demonstrated superior sensitivity for adenomas measuring > 25 HU, non-contrast spectral CT provided high discriminative values for adenomas measuring ≤ 25 HU.
    CONCLUSIONS: Spectral attenuation analysis improves the diagnostic performance of non-contrast CT in discriminating lipid-poor adrenal adenomas, potentially serving as an alternative to CS-MRI and obviating the necessity for additional diagnostic workup in indeterminate adrenal incidentalomas, particularly for lesions measuring ≤ 25 HU.
    CONCLUSIONS: Incidental adrenal lesion detection has increased as abdominal CT use has become more frequent. Non-contrast spectral CT and CS-MRI differentiated lipid-poor adenomas from non-adenomas better than conventional non-contrast CT. For lesions measuring ≤ 25 HU, spectral CT may obviate the need for additional evaluation.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    医疗技术的进步彻底改变了我们诊断各种疾病过程的能力。传统的单能量计算机断层扫描(SECT)在某些临床环境中提供明确的诊断具有多个固有的局限性。自2006年以来,双能计算机断层扫描(DECT)一直在使用,并不断发展,提供各种应用,以帮助放射科医生达到某些诊断SECT无法识别。DECT还可以通过支持放射科医师在某些具有临床挑战性的情况下自信地进行诊断来补充SECT的作用。在这篇评论文章中,我们简要介绍了X射线衰减的原理。我们详细介绍了DECT的原理,并描述了与该技术相关的多个系统。我们描述了各种DECT技术和算法,包括虚拟单能量成像(VMI),虚拟非对比(VNC)成像,碘定量技术,包括碘叠加图(IOM),以及可用于演示多种病理的两种和三种材料分解算法。最后,我们为读者提供有关DECT的各种技术在胃肠道的实际实施的例子的评论,泌尿生殖系统,胆道,肌肉骨骼,和神经放射学系统。
    Advancing medical technology revolutionizes our ability to diagnose various disease processes. Conventional Single-Energy Computed Tomography (SECT) has multiple inherent limitations for providing definite diagnoses in certain clinical contexts. Dual-Energy Computed Tomography (DECT) has been in use since 2006 and has constantly evolved providing various applications to assist radiologists in reaching certain diagnoses SECT is rather unable to identify. DECT may also complement the role of SECT by supporting radiologists to confidently make diagnoses in certain clinically challenging scenarios. In this review article, we briefly describe the principles of X-ray attenuation. We detail principles for DECT and describe multiple systems associated with this technology. We describe various DECT techniques and algorithms including virtual monoenergetic imaging (VMI), virtual non-contrast (VNC) imaging, Iodine quantification techniques including Iodine overlay map (IOM), and two- and three-material decomposition algorithms that can be utilized to demonstrate a multitude of pathologies. Lastly, we provide our readers commentary on examples pertaining to the practical implementation of DECT\'s diverse techniques in the Gastrointestinal, Genitourinary, Biliary, Musculoskeletal, and Neuroradiology systems.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    UNASSIGNED: To assess the usefulness of various metal artifact reduction (MAR) methods in patients with hip prostheses.
    UNASSIGNED: This retrospective study included 47 consecutive patients who underwent hip arthroplasty and dual-energy CT. Conventional polyenergetic image (CI), orthopedic-MAR (O-MAR), and virtual monoenergetic image (VMI, 50-200 keV) were tested for MAR. Quantitative analysis was performed in seven regions around the prostheses. Qualitative assessments included evaluation of the degree of artifacts and the presence of secondary artifacts.
    UNASSIGNED: The lowest amount of image noise was observed in the O-MAR, followed by the VMI. O-MAR also showed the lowest artifact index, followed by high-keV VMI in the range of 120-200 keV (soft tissue) or 200 keV (bone). O-MAR had the highest contrast-to-noise ratio (CNR) in regions with severe hypodense artifacts, while VMI had the highest CNR in other regions, including the periprosthetic bone. On assessment of the CI of pelvic soft tissues, VMI showed a higher structural similarity than O-MAR. Upon qualitative analysis, metal artifacts were significantly reduced in O-MAR, followed by that in VMI, while secondary artifacts were the most frequently found in the O-MAR (p < 0.001).
    UNASSIGNED: O-MAR is the best technique for severe MAR, but it can generate secondary artifacts. VMI at high keV can be advantageous for evaluating periprosthetic bone.
    UNASSIGNED: 고관절 인공치환물을 가진 환자에서 여러 가지 금속인공물 감소 효과를 비교하였다.
    UNASSIGNED: 이 연구는 고관절 인공치환술과 이중에너지 전산화단층촬영을 시행한 47명 환자에서 시행하였다. 금속에서 발생한 인공물 감소효과는 서로 다른 3개의 영상(고식적 영상, 금속인공물 감소영상, 가상 단일에너지 영상)에서 비교하였다. 이를 위해 인공관절 주변 7곳에서 금속인공물에 대한 정량적 분석과 정성적 분석을 시행하였다.
    UNASSIGNED: 금속인공물 감소영상에서 가장 낮은 영상잡음과 인공물 지수를 보였고, 다음으로는 가상 단일에너지 영상이었다. 금속인공물 감소영상은 저음영 인공물이 매우 심한 영역에서만 높은 대조도를 보인 반면, 가상 단일에너지 영상은 인공물 주변 골조직과 그 외 영역에서 높은 대조도를 보였다. 연부조직 분석에서도 금속인공물 감소영상이 더 우수함을 보여 주었다. 정성적 분석에서도 금속인공물 감소영상이 가상 단일에너지 영상보다 인공물 감소 효과가 뛰어남을 밝혔지만, 이차적인 인공물 발생도 가장 흔히 발생하였다.
    UNASSIGNED: 금속인공물 감소영상이 심한 금속인공물감소에 가장 뛰어난 효과를 보였지만 새로운 이차적 인공물을 발생시켰다. 가상 단일에너지 영상은 인공물 주변 골조직 평가에서 우수함을 보였다.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    The third-generation dual-source computed tomography (DSCT) is among the most advanced imaging methods. It employs noise-optimized virtual monoenergetic imaging (VMI+) technology. It uses the frequency-split method to extract high-contrast image information from low-energy images and low-noise information from images reconstructed at an optimal energy level, combining them to obtain the final image with improved quality. This review is the first to summarize the results of clinical studies that primarily and recently evaluated the VMI+ technique based on tumor, blood vessel, and other lesion classification. We aim to assist radiologists in quickly selecting the appropriate energy level when performing image reconstruction for superior image quality in clinical work and providing several ideas for future scientific research of the VMI+ technique. Presently, VMI+ reconstruction is mostly used for images of various tumors or blood vessels, including coronary plaques, coronary stents, deep vein thromboses, pulmonary embolisms (PEs), active arterial hemorrhages, and endoleaks after endovascular aneurysm repair. In addition, VMI+ has been used for imaging children\'s heads, liver lesions, pancreatic lacerations, and reducing metal artifacts. Regarding the reconstruction at the optimal energy level, the VMI+ technique yielded a higher image quality than the pre-optimized virtual monoenergetic imaging (VMI) technique and single-energy CT. Moreover, either low concentrations of contrast medium or low iodine injection rates can be applied before VMI+ reconstruction at a low-energy level to reduce contrast agent-related kidney injury risk. After reconstructing an image at the optimal energy level, both the image\'s window width and level can also be adjusted to improve the image effect\'s reach and diagnosis suitability. To improve image quality and lesion-imaging clarity and reduce the use of contrast agents, VMI+ reconstruction technology has been applied clinically, in which the selection of energy level is the key to the whole reconstruction process. Our review summarizes these optimal levels for radiologists\' reference and suggests new ideas for the direction of future VMI+ research.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号